GEODE CAPITAL MANAGEMENT, LLC

Holdings History for Tarsus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (TARS)

Symbol: TARS on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$77,616,160	947,763	+3,267	+0.35%	$81.89	Q4 2025
30 Sep 2025	0%	+0%	$56,140,457	944,496	+10,076	+1.1%	$59.44	Q3 2025
30 Jun 2025	0%	+0%	$37,858,822	934,420	+68,986	+8%	$40.52	Q2 2025
31 Mar 2025	0%	+0%	$44,467,400	865,434	+26,630		$51.38	Q1 2025
31 Dec 2024	0%	+0%	$46,455,645	838,804	+3,014	+0.36%	$55.38	Q4 2024
30 Sep 2024	0%	+0%	$27,494,430	835,790	+62,555	+8.1%	$32.90	Q3 2024
30 Jun 2024	0%	+0%	$21,020,137	773,235	+143,543	+23%	$27.18	Q2 2024
31 Mar 2024	0%	+0%	$22,892,539	629,692	+19,956	+3.3%	$36.36	Q1 2024
31 Dec 2023	0%	+0%	$12,348,496	609,736	+83,476	+16%	$20.25	Q4 2023
30 Sep 2023	0%	+0%	$9,352,843	526,260	+81,399	+18%	$17.77	Q3 2023
30 Jun 2023	0%	+0%	$8,038,638	444,861	+95,712	+27%	$18.07	Q2 2023
31 Mar 2023	0%	+0%	$4,388,802	349,149	+7,958	+2.3%	$12.57	Q1 2023
31 Dec 2022	0%	+0%	$5,001,000	341,191	+11,710	+3.6%	$14.66	Q4 2022
30 Sep 2022	0%	+0%	$5,640,000	329,481	+63,397	+24%	$17.12	Q3 2022
30 Jun 2022	0%	+0%	$3,884,000	266,084	+135,326	+103%	$14.60	Q2 2022
31 Mar 2022	0%	+0%	$2,199,000	130,758	+4,943	+3.9%	$16.82	Q1 2022
31 Dec 2021	0%	+0%	$2,830,000	125,815	+2,117	+1.7%	$22.49	Q4 2021
30 Sep 2021	0%	-0%	$2,665,000	123,698	-1,823	-1.5%	$21.54	Q3 2021
30 Jun 2021	0%	+0%	$3,637,000	125,521	+23,712	+23%	$28.98	Q2 2021
31 Mar 2021	0%	-0%	$3,281,000	101,809	-8,566	-7.8%	$32.23	Q1 2021
31 Dec 2020	0%	+0%	$4,561,000	110,375	+110,375	NEW	$41.32	Q4 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.